CardioOnco_JHE Profile Banner
Julius Heemelaar, MD PhD Profile
Julius Heemelaar, MD PhD

@CardioOnco_JHE

Followers
266
Following
1K
Statuses
507

Postdoc on #LLMs in #CardioOnc at LUMC 🇳🇱 former postdoc at CIRC / Mass General Hospital 🇺🇸 | Cardiologist in Training🫀 |

Amsterdam, Nederland
Joined August 2020
Don't wanna be here? Send us removal request.
@CardioOnco_JHE
Julius Heemelaar, MD PhD
11 months
Re-watch my recent webinar and discussion on ⁦@ICOSociety⁩ ⁦@radcliffeCARDIO⁩ channel on how large language models can influence #CardioOnc research 👇👇 The Imminent Digital Revolution in Cardio-Oncology Research
0
3
8
@CardioOnco_JHE
Julius Heemelaar, MD PhD
1 month
RT @JACCJournals: The interplay between #CVD & cancer is bidirectional & #ASCVD resulted in being associated with a significantly increased…
0
5
0
@CardioOnco_JHE
Julius Heemelaar, MD PhD
2 months
RT @JACCJournals: A consensus of #CardioOnc experts on cardioprotection, #cardiotoxicity surveillance and permissive cardiotoxicity during…
0
45
0
@CardioOnco_JHE
Julius Heemelaar, MD PhD
3 months
0
0
1
@CardioOnco_JHE
Julius Heemelaar, MD PhD
3 months
Wow spectacular work!
@TomasNeilan
Tomas G. Neilan, MD, MPH
3 months
In @Nature, a collaboration with @kreynoldsMD, @villanilab, @sm_blum, @DZlotoff from @MGHCancerCenter, @MGHMedicine and others. Immune response in checkpoint myocarditis. Sincere thanks to the patients and families. @mghcvrc @ICOSociety. @MGHHeartHealth
0
0
0
@CardioOnco_JHE
Julius Heemelaar, MD PhD
3 months
Congratulations to Daniel Faria, @JEscaned and collagues for this publication! Age‐related structural remodelling of the coronary circulation - Faria - 2024 - Catheterization and Cardiovascular Interventions - Wiley Online Library
0
1
2
@CardioOnco_JHE
Julius Heemelaar, MD PhD
4 months
The defence of my thesis on the changing landscape of #CardioOnc research is one week away 🙏 any last advices? #AcademicChatter #CardioTwitter @ThePhDPlace @PhDVoice
Tweet media one
0
0
3
@CardioOnco_JHE
Julius Heemelaar, MD PhD
5 months
RT @BiykemB: Everything you wanted regarding #obesity management in #heartfailure in this outstanding review @NutritionHF Review of all tri…
0
87
0
@CardioOnco_JHE
Julius Heemelaar, MD PhD
5 months
Pleasant start to weekend shift at the hospital @olvg 🌈
Tweet media one
0
0
2
@CardioOnco_JHE
Julius Heemelaar, MD PhD
5 months
Mooi moment in de lichtstraat, muzikaal vermaak in de apotheek wachtkamer van het @olvg
Tweet media one
0
0
0
@CardioOnco_JHE
Julius Heemelaar, MD PhD
5 months
Arterial inflammation (PET-CT) increased in pts with advanced #melanoma on #ICI #immunotherapy compared to controls. Mechanism for CV events? Now published in @ATHjournal #Atherosclerosis #CardioOnc 👏 Elissa Polomski & @LouisaAntoni
0
2
3
@CardioOnco_JHE
Julius Heemelaar, MD PhD
5 months
Congratulations for this well written #CardioOnc overview
@Massimi78530343
Massimiliano Camilli
5 months
🫀Anthracycline Cardiotoxicity in Adult Cancer Patients. JACC CardioOncology State-of-the-Art Review. I thank my mentors for having guided me towards publication📝. Many points should still be addressed in anthracycline cardiotoxity 🔬 and the future of CardioOncology is bright☀️
Tweet media one
0
0
2
@CardioOnco_JHE
Julius Heemelaar, MD PhD
5 months
@kingoftobat @JCO_ASCO @ginny314gs @kreynoldsMD @TomasNeilan The development of LLMs was a huge game changer from these AI autotransciber tools! It will save a huge amount of time to be able to listen to the patient in stead of typing everything into the PC . I guess the next gen med students may no longer use a keyboards in the clinic 😅
0
0
0
@CardioOnco_JHE
Julius Heemelaar, MD PhD
5 months
RT @JCO_ASCO: Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and Inte…
0
2
0
@CardioOnco_JHE
Julius Heemelaar, MD PhD
5 months
Luckily this study may provide a solution! Link to paper 👉 A special thanks @kreynoldsMD Severe Immunotherapy Complications service team for their years long effort on the registry that served as the gold standard for this study 👏 👏
0
0
0
@CardioOnco_JHE
Julius Heemelaar, MD PhD
5 months
RT @DrJFriedberg: Enhancing Precision in Detecting Severe Immune-Related Adverse Events: use of large language models required 9 seconds/ch…
0
10
0
@CardioOnco_JHE
Julius Heemelaar, MD PhD
5 months
0
2
0